iBio Inc. (IBIO)
NASDAQ: IBIO
· Real-Time Price · USD
0.85
0.00 (0.53%)
At close: Oct 17, 2025, 3:59 PM
0.84
-0.93%
After-hours: Oct 17, 2025, 05:06 PM EDT
iBio Income Statement
Financials in USD. Fiscal
year is
July - June.
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Period Ending | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 | Jun 30, 2021 |
Revenue | 400K | 225K | n/a | 1.88M | 2.37M |
Cost of Revenue | n/a | 1.25M | 1.11M | 216K | 1.46M |
Gross Profit | n/a | 225K | -1.11M | 2.17M | 909K |
Operating Income | -18.38M | -16.63M | -29.31M | -29.7M | -31.11M |
Interest Income | 437K | 363K | 130K | 177K | 140K |
Pretax Income | n/a | -15.44M | -29.31M | -29.51M | -23.21M |
Net Income | n/a | -24.91M | -29.31M | -51.01M | -23.21M |
Selling & General & Admin | 10.69M | 11.67M | 18.45M | 21.75M | 22.03M |
Research & Development | 8.31M | 5.18M | 10.33M | 9.83M | 9.99M |
Other Expenses | n/a | n/a | 565K | 13K | 12K |
Operating Expenses | 19M | 16.86M | 29.34M | 31.36M | 32.02M |
Interest Expense | -212K | 172K | n/a | n/a | 2.45M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | 16.86M | 29.34M | 52.07M | 33.48M |
Income Tax Expense | n/a | n/a | n/a | 701K | 46K |
Shares Outstanding (Basic) | 10.5M | 3.83M | 1.23M | 872.1K | 391.24K |
Shares Outstanding (Diluted) | 10.5M | 3.83M | 1.23M | 872.1K | 391.24K |
EPS (Basic) | -1.75 | -6.5 | -23.94 | -58.49 | -60 |
EPS (Diluted) | -1.75 | -6.5 | -23.94 | -58.49 | -60 |
EBITDA | -18.38M | -14.02M | -28.12M | -25.72M | -18.34M |
EBIT | n/a | -15.27M | -29.23M | -29.51M | -20.76M |
Depreciation & Amortization | n/a | 1.25M | 1.11M | 3.79M | 2.41M |
Source: Financial Modeling Prep. Financial Sources.